(Q37930965)

25 August 2017

1 reference

title

Restenosis after PCI. Part 1: pathophysiology and risk factors (English)

1 reference

25 August 2017

1 reference

1

J Wouter Jukema

1 reference

25 August 2017

author name string

Jeffrey J W Verschuren

series ordinal

2

1 reference

25 August 2017

Tarek A N Ahmed

series ordinal

3

1 reference

25 August 2017

Paul H A Quax

series ordinal

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

13 September 2011

1 reference

Nature Reviews Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

9

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

53-62

1 reference

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The relationship between late lumen loss and restenosis among various drug-eluting stents: A systematic review and meta-regression analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Drug-eluting stents in vascular intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Drug eluting stents: an updated meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Genetic predictive factors in restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Restenosis: the cost to society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Can restenosis after coronary angioplasty be predicted from clinical variables?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

In-stent restenosis in the drug-eluting stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Intravascular ultrasound assessment of drug-eluting stent expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Meta-Analysis of Incidence, Clinical Characteristics and Implications of Stent Fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Does smoking cessation reduce the risk of restenosis following coronary angioplasty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The evolving role of inflammatory biomarkers in risk assessment after stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Tumor necrosis factor-alpha plays an important role in restenosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Important role of TNF-alpha in inhibitory effects of Radix Sophorae Flavescentis extract on vascular restenosis in a rat carotid model of balloon dilatation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Plasminogen activator inhibitor-1 and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Looking for the culprit of coronary in-stent restenosis: debatable role for the fibrinolytic system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of reste

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Understanding the role of endothelial progenitor cells in cardiovascular disease, coronary artery lesion progression, and in-stent restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: A study in patients with and without the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (REGENT I extension).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Genetic risk for restenosis after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Coronary stents: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two‐year angiographic and three‐year clinical results from the SPIRIT II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Evidence for use of coronary stents. A hierarchical bayesian meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

D Allele of the Angiotensin I–Converting Enzyme Is a Major Risk Factor for Restenosis After Coronary Stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

A potent genetic risk factor for restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Predictive Factors of Restenosis After Coronary Stent Placement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Metal allergic reaction in chronic refractory in-stent restenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Evaluation of metal allergies in patients with coronary stents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Thrombin is bad, accepted; but is smoking good to prevent restenosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

In-Stent Restenosis: Contributions of Inflammatory Responses and Arterial Injury to Neointimal Hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Inhibition of Complement Component C3 Reduces Vein Graft Atherosclerosis in Apolipoprotein E3–Leiden Transgenic Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Restenosis is associated with decreased coronary artery nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Genetics and epigenetics--nature's pen-and-pencil set

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Stented segment length as an independent predictor of restenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Meta-Analysis of Randomized Studies Comparing Intravascular Ultrasound Versus Angiographic Guidance of Percutaneous Coronary Intervention in Pre–Drug-Eluting Stent Era

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.132

Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation

31 March 2020

1 reference

12 December 2020

Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention

1 reference

12 December 2020

Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions

1 reference

12 December 2020

Impact of C-reactive protein on in-stent restenosis: a meta-analysis

1 reference

12 December 2020

Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.

1 reference

12 December 2020

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions

1 reference

12 December 2020

Pathophysiology of stem cells in restenosis

1 reference

12 December 2020

Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.

1 reference

12 December 2020

10.1038/NRCARDIO.2011.132

Identifiers

DOI

1 reference

25 August 2017

1 reference